Secondary Antibodies Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC808

Introduction

Primary antibodies are binded by secondary antibodies to support in detection, purification and sorting of aimed antigens. Secondary antibody is particularly effective in immune labeling. Secondary antibodies assistances in increasing signal amplification and sensitivity owing to its property of binding to primary antibodies. Secondary antibodies can consolidate to enzymes such as alkaline phosphatase (AP) or horseradish peroxidase (HRP).

Market Dynamics

Increased expenses in the life science sector, rising association between academic and industries, institutes, growing R&D activities are some of the factors driving the growth of this market. Conversely, vast technical demand and high cost are impeding growth of secondary antibodies market. High growth in the emerging countries and growing demand for modified medicine are expected to propel growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of application, product and geography. By application, secondary antibodies market can be segmented into ELISA, western blot, immunostaining, immunohistochemistry and immunocytochemistry. By product, secondary antibodies market can be segmented into men' and animals'. On the basis of geography, the secondary antibodies market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Secondary Antibodies Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Application, Product, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in secondary antibodies market include EMD Millipore, Rockland Immuno Chemicals, Kirkegaard & Perry Laboratories, R&D Systems, BioLegend, Acris Antibodies, Sino Biological and BioLogo among others.

Market Segmentation

Market By Application

  • ELISA (Including Many HIV Tests)
  • Western Blot
  • Immunostaining
  • Immunohistochemistry
  • Immunocytochemistry

Market By Product

  • Men'
  • Animals'

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary